Feature | Treatment Planning | July 07, 2022 | Information provided by Grand View Research
Accuray Precision Treatment Planning System For CyberKnife

Accuray Precision Treatment Planning System For CyberKnife


The global treatment planning systems and advanced image processing market size was valued at USD 1.7 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 8.3% from 2022 to 2030, according to new data from Grand View Research. The growing prevalence of cancer and increasing medical imaging procedures are driving the demand, which in turn is anticipated to drive the market growth over the forecast years. The growing demand for innovative and accurate cancer treatment using advanced image processing technology is further supporting to the rising penetration of the market all over the globe. Evolving healthcare IT infrastructure and growing adoption of machine learning (ML) and artificial intelligence (AI) for oncology treatment practices is also fueling market growth.

Growing Prevalence of Cancer

The increasing focus of the market players to invest in the innovation of advanced technology in order to hold a strong position in the global market is also anticipated to accelerate market growth. The rapidly increasing mortalities due to cancer at both regional and global levels is boosting the demand for advanced and innovative treatment practices. For instance, as per 2020 Globocan estimates, about10 million cancer-related mortalities and approximately 19.3 million new cancer cases were diagnosed globally. Breast cancer is the most common type of cancer contributing about 11.7% of all cancer types followed by lung cancer (11.4%), colorectal cancer (10.0%), prostate cancer (7.3%) and stomach cancer (5.6%). In addition, the growing prevalence of cancer coupled with the demand for adequate treatment plans for better clinical outcomes is also anticipated to accelerate the growth of the market for treatment planning systems and advanced image processing.

The growing popularity of radiotherapy for the diagnosis and treatment of cancer is one of the prominent factors for the growth of the market for treatment planning systems and advanced image processing. According to an article published by the American Cancer Society in June 2019, about half (49%) of the early-stage breast cancer patients undergo breast-conserving surgery (BCS) with adjuvant radiation therapy for the treatment due to its increased efficiency. In addition, several government initiatives to develop modern healthcare infrastructure for the oncology diagnosis using advanced medical imaging technology are further anticipated to accelerate market growth over the years.

The Role of AI

The increasing adoption of artificial intelligence and machine learning by the market players to develop oncology software solutions to enhance treatment plans, diagnosis and management of cancer is further supporting to the growth of the market for treatment planning systems and advanced image processing. In addition, the increasing initiatives and projects were undertaken to develop health information learning platforms to support improved quality of care for oncology which is also anticipated to boost market growth.

Component Insights

The treatment planning software segment accounted for the highest revenue share of 88.1% in 2021. This high segment share is attributable to the growing prevalence of cancer and increasing demand for accurate and advanced oncology therapy solutions. The increasing awareness regarding the adoption of treatment planning software solutions due to its efficiency in cancer treatment using radiotherapy is further propelling the growth of the segment. In addition, advancements in healthcare infrastructure, increasing public-private partnerships, and preference to use software solutions over conventional practice are some of the major factors attributable to the high revenue share of the segment.

However, the highest growth rate is the advanced image processing software segment during the forecast period. The increasing demand for radiology procedures for the diagnosis and treatment of cancer and the growing adoption of advanced medical imaging solutions are anticipated to boost the segment growth over the years. The increasing number of imaging modalities and growing modern radiology facilities all over the globe with AI-incorporated advanced image processing software are further anticipated to accelerate the growth of the segment. In addition, the shortage of trained radiology professionals is further boosting the demand for advanced image processing solutions.

View the Treatment Planning Systems Comparison Chart


Related Content

News | Enterprise Imaging

June 9, 2026 — GE HealthCare will showcase its latest enterprise imaging solutions at the Society for Imaging ...

Time June 09, 2026
arrow
News | Innovative Hospitals

May 27, 2026 — Nearly two years after announcing plans for a “real-world” academic-industrial collaboration, GE ...

Time June 03, 2026
arrow
News | Radiopharmaceuticals and Tracers

May 27, 2026 — Subtle Medical has received FDA clearance for its SubtleHD (PET), the company's next-generation AI ...

Time May 27, 2026
arrow
News | FDA

May 19, 2026 — DeepHealth has received the CE Mark for the Brain Health and Brain Age solutions within its Neuro Suite ...

Time May 26, 2026
arrow
News | Radiology Business

May 22, 2026 — The American College of Radiology (ACR) supports passage of the Medicare Access to Radiology Care Act (S ...

Time May 26, 2026
arrow
News | Radiology Business

May 22, 2026 — U.S. Sens. Boozman, R-AR, and Luján, D-NM, have introduced the Medicare Access to Radiology Care Act ...

Time May 26, 2026
arrow
News | Cardiac Imaging

May 21, 2026 — A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s ...

Time May 22, 2026
arrow
News | X-Ray

May 21, 2026 — RADIN Health and AZmed have announced the expansion of their strategic partnership and enhance radiology ...

Time May 22, 2026
arrow
News | Digital Pathology

May 7, 2026 — Roche has entered into a definitive merger agreement to acquire PathAI, a U.S.-based company in digital ...

Time May 21, 2026
arrow
News | Computed Tomography (CT)

May 12, 2026 – Bracco Imaging S.p.A. has purchased a mobile photon-counting CT scanner from MARS Bioimaging to support ...

Time May 20, 2026
arrow
Subscribe Now